Luoxin Pharmaceuticals Group Stock Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000026S7
CNY
5.36
0.1 (1.9%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
585.25
477.85
759.35
617.57
565.87
683.70
530.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
585.25
477.85
759.35
617.57
565.87
683.70
530.27
Raw Material Cost
296.44
278.98
464.16
331.10
337.09
456.71
334.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.77
15.69
18.48
16.43
15.93
14.86
13.75
Selling and Distribution Expenses
239.96
153.76
447.03
411.30
277.18
250.57
423.79
Other Expenses
0.41
-0.24
1.82
0.12
-0.55
-0.38
-0.29
Total Expenditure (Excl Depreciation)
553.23
446.09
947.87
760.03
624.69
718.33
768.72
Operating Profit (PBDIT) excl Other Income
32
31.8
-188.5
-142.5
-58.8
-34.6
-238.4
Other Income
11.29
5.80
72.67
6.21
24.20
8.65
-24.93
Operating Profit (PBDIT)
92.77
91.78
-393.31
-106.83
9.03
25.79
-305.04
Interest
12.77
15.69
18.48
16.43
15.93
14.86
13.75
Exceptional Items
0.00
0.00
-213.13
0.00
0.00
0.00
-4.05
Gross Profit (PBDT)
288.81
198.87
295.19
286.48
228.77
226.99
196.16
Depreciation
56.70
56.70
51.96
51.96
53.83
53.83
51.92
Profit Before Tax
23.30
19.38
-676.88
-175.22
-60.73
-42.90
-374.76
Tax
2.22
13.83
73.14
15.15
6.58
4.53
123.44
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
12.04
5.65
-700.13
-176.66
-52.05
-36.66
-431.63
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
12.04
5.65
-700.13
-176.66
-52.05
-36.66
-431.63
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
7.81
-3.50
-34.53
-19.55
-19.71
-12.97
-50.71
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.85
2.15
-734.66
-196.21
-71.76
-49.63
-482.34
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,412.79
1,394.94
1,382.28
2,104.12
2,283.01
2,334.56
2,469.90
Earnings per share (EPS)
0.01
0.01
-0.65
-0.17
-0.05
-0.03
-0.4
Diluted Earnings per share
0.01
0.01
-0.65
-0.17
-0.05
-0.03
-0.4
Operating Profit Margin (Excl OI)
4.23%
6.13%
-68.21%
-26.72%
-12.19%
-5.37%
-62.62%
Gross Profit Margin
13.67%
15.92%
-82.3%
-19.96%
-1.22%
1.6%
-60.88%
PAT Margin
2.06%
1.18%
-92.2%
-28.61%
-9.2%
-5.36%
-81.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 22.48% vs -37.08% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 842.86% vs 100.29% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -5.23% vs 118.45% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -18.47% vs -15.14% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Luoxin Pharmaceuticals Group Stock Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
585.25
0
585.25
Other Operating Income
0.00
0.00
0.00
Total Operating income
585.25
0
585.25
Raw Material Cost
296.44
0
296.44
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.77
0
12.77
Selling and Distribution Expenses
239.96
0
239.96
Other Expenses
0.41
0.00
0.41
Total Expenditure (Excl Depreciation)
553.23
0
553.23
Operating Profit (PBDIT) excl Other Income
32.02
0.00
32.02
Other Income
11.29
0
11.29
Operating Profit (PBDIT)
92.77
0
92.77
Interest
12.77
0
12.77
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
288.81
0
288.81
Depreciation
56.70
0
56.70
Profit Before Tax
23.30
0
23.30
Tax
2.22
0
2.22
Provisions and contingencies
0
0
0.00
Profit After Tax
12.04
0
12.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
12.04
0
12.04
Share in Profit of Associates
0
0
0.00
Minority Interest
7.81
0
7.81
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.85
0
19.85
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,412.79
0
1,412.79
Earnings per share (EPS)
0.01
0
0.01
Diluted Earnings per share
0.01
0
0.01
Operating Profit Margin (Excl OI)
4.23%
0%
0.00
4.23%
Gross Profit Margin
13.67%
0%
0.00
13.67%
PAT Margin
2.06%
0%
0.00
2.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 58.52 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 22.48% vs -37.08% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 3.41% vs -3.91% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.98 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 842.86% vs 100.29% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 127.58% vs -23.37% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.15 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -5.23% vs 118.45% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 636.18% vs -183.52% in Jun 2024

Quarterly - Interest
Interest 1.28 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -18.47% vs -15.14% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -19.50% vs -29.02% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.23%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024